Literature DB >> 21536993

Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension.

Yoshio Matsui1, Joji Ishikawa, Kazuo Eguchi, Seiichi Shibasaki, Kazuyuki Shimada, Kazuomi Kario.   

Abstract

The maximum office systolic blood pressure (SBP) has been shown to be a strong predictor of cardiovascular events, independently of the mean SBP level. However, the clinical implications of maximum home SBP have never been reported. We investigated the association between the maximum home SBP and target organ damage (TOD). We assessed the left ventricular mass index (LVMI) and carotid intima-media thickness (IMT) using ultrasonography and the urinary albumin/creatinine ratio (UACR) as measures of TOD in 356 never-treated hypertensive subjects. Home BP was taken in triplicate in the morning and evening, respectively, for 14 consecutive days with a memory-equipped device. The maximum home SBP was defined as the maximum mean triplicate BP reading in the 14-day period for each individual and was significantly correlated with LVMI (r=0.51, P<0.001), carotid IMT (r=0.40, P<0.001), and UACR (r=0.29, P<0.001). The correlation coefficients with LVMI and carotid IMT were significantly larger for the maximum home SBP than the mean home SBP. In multivariate regression analyses, the maximum home SBP was independently associated with LVMI and carotid IMT, regardless of the mean home BP level. In the prediction of left ventricular hypertrophy and carotid atherosclerosis, the goodness-of-fit of the model was significantly improved when the maximum home SBP was added to the sum of the mean office and home BPs (P=0.002 and P<0.001, respectively). These findings indicate that assessment of the maximum home SBP, in addition to the mean home SBP, might increase the predictive value of hypertensive TOD in the heart and artery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21536993     DOI: 10.1161/HYPERTENSIONAHA.111.171645

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  35 in total

Review 1.  Is It Daily, Monthly, or Yearly Blood Pressure Variability that Enhances Cardiovascular Risk?

Authors:  Eamon Dolan; Eoin O'Brien
Journal:  Curr Cardiol Rep       Date:  2015-11       Impact factor: 2.931

2.  Increased nocturnal blood pressure variability is associated with renal arteriolar hyalinosis in normotensive patients with IgA nephropathy.

Authors:  Shinsuke Isobe; Naro Ohashi; Sayaka Ishigaki; Naoko Tsuji; Takayuki Tsuji; Akihiko Kato; Hideo Yasuda
Journal:  Hypertens Res       Date:  2017-07-13       Impact factor: 3.872

Review 3.  Blood pressure variability: assessment, predictive value, and potential as a therapeutic target.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2015-04       Impact factor: 5.369

Review 4.  Assessment and management of blood-pressure variability.

Authors:  Gianfranco Parati; Juan E Ochoa; Carolina Lombardi; Grzegorz Bilo
Journal:  Nat Rev Cardiol       Date:  2013-02-12       Impact factor: 32.419

5.  Maximum home blood pressure readings are associated with left atrial diameter in essential hypertensives.

Authors:  Toshiki Kaihara; Yuki Imaizumi; Kazuo Eguchi; Kazuomi Kario
Journal:  J Hum Hypertens       Date:  2018-05-01       Impact factor: 3.012

Review 6.  Effects of Antihypertensive Therapy on Blood Pressure Variability.

Authors:  Kazuo Eguchi
Journal:  Curr Hypertens Rep       Date:  2016-10       Impact factor: 5.369

Review 7.  Blood pressure variability, cardiovascular risk, and risk for renal disease progression.

Authors:  Gianfranco Parati; Juan E Ochoa; Grzegorz Bilo
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

Review 8.  Blood pressure variability: its relevance for cardiovascular homeostasis and cardiovascular diseases.

Authors:  Gianfranco Parati; Camilla Torlasco; Martino Pengo; Grzegorz Bilo; Juan Eugenio Ochoa
Journal:  Hypertens Res       Date:  2020-03-13       Impact factor: 3.872

Review 9.  Hypertension, Blood Pressure Variability, and Target Organ Lesion.

Authors:  Maria-Cláudia Irigoyen; Kátia De Angelis; Fernando Dos Santos; Daniela R Dartora; Bruno Rodrigues; Fernanda Marciano Consolim-Colombo
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

10.  Aliskiren reduces home blood pressure and albuminuria in patients with hypertensive nephrosclerosis.

Authors:  Hiroko Suzuki; Kazuyoshi Okada; Masanori Abe; Noriaki Maruyama; Yoshinori Yoshida; Seishiro Baba; Hiroyuki Takashima; Masayoshi Soma
Journal:  Clin Exp Nephrol       Date:  2012-11-09       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.